C3RY Fundamental Analysis - CHERRY SE

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to C3RY. C3RY was compared to 30 industry peers in the Technology Hardware, Storage & Peripherals industry. C3RY may be in some trouble as it scores bad on both profitability and health. C3RY is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

C3RY had negative earnings in the past year.

C3RY had a negative operating cash flow in the past year.

C3RY had negative earnings in 4 of the past 5 years.

Of the past 5 years C3RY 4 years had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -39.19%, C3RY is not doing good in the industry: 93.33% of the companies in the same industry are doing better.

With a Return On Equity value of -86.01%, C3RY is not doing good in the industry: 80.00% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-39.19%
ROE	-86.01%
ROIC	N/A

ROA(3y)-29.88%

ROA(5y)-18%

ROE(3y)-58.91%

ROE(5y)-35.77%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

C3RY's Gross Margin of 12.12% is on the low side compared to the rest of the industry. C3RY is outperformed by 83.33% of its industry peers.

C3RY's Gross Margin has declined in the last couple of years.

C3RY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	12.12%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-19.07%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

C3RY does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, C3RY has about the same amount of shares outstanding.

C3RY has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -2.26, we must say that C3RY is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of C3RY (-2.26) is worse than 83.33% of its industry peers.

C3RY has a Debt/Equity ratio of 0.54. This is a neutral value indicating C3RY is somewhat dependend on debt financing.

C3RY has a Debt to Equity ratio (0.54) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.54
Debt/FCF	N/A
Altman-Z	-2.26

ROIC/WACCN/A

WACC4.99%

2.3 Liquidity

A Current Ratio of 2.21 indicates that C3RY has no problem at all paying its short term obligations.

The Current ratio of C3RY (2.21) is better than 73.33% of its industry peers.

A Quick Ratio of 0.87 indicates that C3RY may have some problems paying its short term obligations.

C3RY's Quick ratio of 0.87 is on the low side compared to the rest of the industry. C3RY is outperformed by 60.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.21
Quick Ratio	0.87

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

C3RY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.06%, which is quite impressive.

The Revenue for C3RY has decreased by -25.12% in the past year. This is quite bad

C3RY shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -13.14% yearly.

EPS 1Y (TTM)58.06%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-164.29%

Revenue 1Y (TTM)-25.12%

Revenue growth 3Y-13.14%

Revenue growth 5YN/A

Sales Q2Q%-33.9%

3.2 Future

C3RY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.61% yearly.

C3RY is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.13% yearly.

EPS Next Y-26.94%

EPS Next 2Y27.32%

EPS Next 3Y25.61%

EPS Next 5YN/A

Revenue Next Year-11.95%

Revenue Next 2Y-3.24%

Revenue Next 3Y0.19%

Revenue Next 5Y2.13%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for C3RY. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for C3RY. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

C3RY's earnings are expected to grow with 25.61% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y27.32%

EPS Next 3Y25.61%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

C3RY does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

CHERRY SE

FRA:C3RY (12/15/2025, 7:00:00 PM)

0.592

-0.01 (-1%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryTechnology Hardware, Storage & Peripherals

Earnings (Last)08-14 2023-08-14/bmo

Earnings (Next)N/A N/A

Inst Owners32.85%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap14.39M

Revenue(TTM)94.89M

Net Income(TTM)-53.27M

Analysts44

Price Target0.66 (11.49%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-32.29%

PT rev (3m)-28.31%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-49.46%

EPS NY rev (3m)-214.12%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-3.48%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.15
P/FCF	N/A
P/OCF	N/A
P/B	0.23
P/tB	1.77
EV/EBITDA	N/A

EPS(TTM)-2.26

EYN/A

EPS(NY)-0.28

Fwd EYN/A

FCF(TTM)-0.54

FCFYN/A

OCF(TTM)-0.22

OCFYN/A

SpS3.9

BVpS2.55

TBVpS0.33

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-39.19%
ROE	-86.01%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	12.12%
FCFM	N/A

ROA(3y)-29.88%

ROA(5y)-18%

ROE(3y)-58.91%

ROE(5y)-35.77%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-19.07%

GM growth 5YN/A

F-Score4

Asset Turnover0.7

Health

		Industry Rank	Sector Rank
Debt/Equity	0.54
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	21.24%
Cap/Sales	8.12%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.21
Quick Ratio	0.87
Altman-Z	-2.26

F-Score4

WACC4.99%

ROIC/WACCN/A

Cap/Depr(3y)17.41%

Cap/Depr(5y)38.92%

Cap/Sales(3y)6.91%

Cap/Sales(5y)6.78%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)58.06%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-164.29%

EPS Next Y-26.94%

EPS Next 2Y27.32%

EPS Next 3Y25.61%

EPS Next 5YN/A

Revenue 1Y (TTM)-25.12%

Revenue growth 3Y-13.14%

Revenue growth 5YN/A

Sales Q2Q%-33.9%

Revenue Next Year-11.95%

Revenue Next 2Y-3.24%

Revenue Next 3Y0.19%

Revenue Next 5Y2.13%

EBIT growth 1Y35.43%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year8%

EBIT Next 3Y44.3%

EBIT Next 5YN/A

FCF growth 1Y57.45%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y74.18%

OCF growth 3Y-28.61%

OCF growth 5YN/A

CHERRY SE / C3RY.DE FAQ

What is the ChartMill fundamental rating of CHERRY SE (C3RY.DE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to C3RY.DE.

What is the valuation status for C3RY stock?

ChartMill assigns a valuation rating of 1 / 10 to CHERRY SE (C3RY.DE). This can be considered as Overvalued.

Can you provide the profitability details for CHERRY SE?

CHERRY SE (C3RY.DE) has a profitability rating of 1 / 10.

Can you provide the financial health for C3RY stock?

The financial health rating of CHERRY SE (C3RY.DE) is 3 / 10.

Can you provide the expected EPS growth for C3RY stock?

The Earnings per Share (EPS) of CHERRY SE (C3RY.DE) is expected to decline by -26.94% in the next year.

CHERRY SE (C3RY.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

CHERRY SE / C3RY.DE FAQ

What is the ChartMill fundamental rating of CHERRY SE (C3RY.DE) stock?

What is the valuation status for C3RY stock?

Can you provide the profitability details for CHERRY SE?

Can you provide the financial health for C3RY stock?

Can you provide the expected EPS growth for C3RY stock?